Debabrata Chanda
Impact in
- Drug Discovery top 0.01%
- Pharmacology and Nanomedicine Research
Papers in
-
- Bioactive Compounds and Antitumor Agents 8
- Co-authors
- Suaib LuqmanArvind S. NegiKaruna ShankerArjun SinghFeroz KhanJayanta SarkarAnil Kumar MauryaSuchita Srivastava
In The Last Decade
Debabrata Chanda
65 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 113
- Drug Discovery 115
- Complementary and alternative medicine 242
- Toxicology 83
- Pharmacology 204
- Organic Chemistry 538
Countries citing papers authored by Debabrata Chanda
This map shows the geographic impact of Debabrata Chanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debabrata Chanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debabrata Chanda more than expected).
Fields of papers citing papers by Debabrata Chanda
This network shows the impact of papers produced by Debabrata Chanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debabrata Chanda. The network helps show where Debabrata Chanda may publish in the future.
Co-authors
The 25 scholars most cited alongside Debabrata Chanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 16 | |
| 10 | 2022 | 15 | |
| 11 | 2021 | 15 | |
| 12 | 2019 | 39 | |
| 13 | 2019 | 7 | |
| 14 | 2018 | 62 | |
| 15 | 2017 | 11 | |
| 16 | 2016 | 46 | |
| 17 | 2014 | 61 | |
| 18 | 2014 | 55 | |
| 19 | 2013 | 32 | |
| 20 | 2013 | 12 |
About Debabrata Chanda
Debabrata Chanda is a scholar working on Toxicology, Applied Microbiology and Biotechnology, Pharmacology, Molecular Medicine and Complementary and alternative medicine, having authored 69 papers that have together received 1.8k indexed citations. Recurring topics across this work include Synthesis and biological activity (18 papers), Bioactive Compounds and Antitumor Agents (8 papers), Computational Drug Discovery Methods (5 papers), Essential Oils and Antimicrobial Activity (5 papers), Natural product bioactivities and synthesis (4 papers), Cancer therapeutics and mechanisms (4 papers), Click Chemistry and Applications (4 papers) and Phytochemistry and Biological Activities (4 papers). The work is most often cited by research in Drug Discovery (115 citations), Complementary and alternative medicine (242 citations), Toxicology (83 citations), Pharmacology (204 citations) and Organic Chemistry (538 citations). Debabrata Chanda has collaborated with scholars based in India, Nigeria and Italy. Frequent co-authors include Suaib Luqman, Arvind S. Negi, Karuna Shanker, Arjun Singh, Feroz Khan, Jayanta Sarkar, Anil Kumar Maurya, Suchita Srivastava, Ritesh Kumar and Rituraj Konwar. Their work appears in journals such as Bioorganic & Medicinal Chemistry, European Journal of Pharmacology, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.